NFKB1 and cancer: TLR2 promotes gastric cancer progression by stimulating proliferation and inhibiting the apoptosis of cancer cells through the activation of the NF-κB, PI3K/AKT, ERK1/2, and JNK MAPK pathways, without inducing an inflammatory response [56].